Singular Genomics Systems, Inc. Common Stock
OMIC
OMIC was delisted on the 20th of February, 2025.
24 hedge funds and large institutions have $6M invested in Singular Genomics Systems, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 11 reducing their positions, and 20 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
43% less funds holding
Funds holding: 42 → 24 (-18)
45% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 11
54% less capital invested
Capital invested by funds: $13.1M → $6M (-$7.05M)
90% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 20
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$16.5K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.85K |
| 3 |
Morgan Stanley
New York
|
+$854 |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$421 |
| 5 |
CAL
Capital Advisors Ltd
Shaker Heights,
Ohio
|
+$386 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$1.14M |
| 2 |
Verition Fund Management
Greenwich,
Connecticut
|
-$257K |
| 3 |
TM
Triatomic Management
Palo Alto,
California
|
-$100K |
| 4 |
Millennium Management
New York
|
-$90.5K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$62.5K |
OMIC Hedge Fund Activity: Q2 2024 in Review
24 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Singular Genomics Systems, Inc. Common Stock (OMIC) for Q2 2024, worth a combined $6M — down 54% from $13.1M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of OMIC and 2 opened new positions — a net loss of 18 holders — while 11 trimmed existing stakes and 6 added.
The largest buyer was Geode Capital Management, adding an estimated $16.5K. The largest seller was UBS Group, exiting entirely with an estimated $1.14M sold.
- 24 institutional investors held Singular Genomics Systems, Inc. Common Stock (OMIC) as of Q2 2024, down from 42 in Q1 2024.
- Funds reported $6M of Singular Genomics Systems, Inc. Common Stock stock for Q2 2024, down 54% quarter-over-quarter.
- 2 funds opened new Singular Genomics Systems, Inc. Common Stock positions in Q2 2024 and 20 closed out, a net change of -18 holders.
- The largest Singular Genomics Systems, Inc. Common Stock buyer in Q2 2024 was Geode Capital Management, an estimated $16.5K added.
- The largest Singular Genomics Systems, Inc. Common Stock seller in Q2 2024 was UBS Group, an estimated $1.14M sold.
Based on aggregated 13F filings for Q2 2024.